These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 14585237)

  • 41. Pathophysiology, diagnosis and treatment of ascites in cirrhosis.
    Arroyo V
    Ann Hepatol; 2002; 1(2):72-9. PubMed ID: 15115971
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Safety, complications and outcome of large volume paracentesis with or without albumin therapy in children with severe ascites due to liver disease.
    Sen Sarma M; Yachha SK; Bhatia V; Srivastava A; Poddar U
    J Hepatol; 2015 Nov; 63(5):1126-32. PubMed ID: 26134185
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Paracentesis with intravenous infusion of albumin as compared with peritoneovenous shunting in cirrhosis with refractory ascites.
    Ginès P; Arroyo V; Vargas V; Planas R; Casafont F; Panés J; Hoyos M; Viladomiu L; Rimola A; Morillas R
    N Engl J Med; 1991 Sep; 325(12):829-35. PubMed ID: 1875966
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ascites: pathogenesis and therapeutic principles.
    Møller S; Henriksen JH; Bendtsen F
    Scand J Gastroenterol; 2009; 44(8):902-11. PubMed ID: 19479632
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Refractory Ascites in Liver Cirrhosis.
    Adebayo D; Neong SF; Wong F
    Am J Gastroenterol; 2019 Jan; 114(1):40-47. PubMed ID: 29973706
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Octreotide in the treatment of refractory ascites of cirrhosis.
    Kalambokis G; Fotopoulos A; Economou M; Tsianos EV
    Scand J Gastroenterol; 2006 Jan; 41(1):118-21. PubMed ID: 16373285
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Predictors of large volume paracantesis induced circulatory dysfunction in patients with massive hepatic ascites.
    Nasr G; Hassan A; Ahmed S; Serwah A
    J Cardiovasc Dis Res; 2010 Jul; 1(3):136-44. PubMed ID: 21187868
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Complications of cirrhosis. II. Renal and circulatory dysfunction. Lights and shadows in an important clinical problem.
    Arroyo V; Jiménez W
    J Hepatol; 2000; 32(1 Suppl):157-70. PubMed ID: 10728802
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Update on peripheral arterial vasodilation, ascites and hepatorenal syndrome in cirrhosis.
    Knotek M; Rogachev B; Schrier RW
    Can J Gastroenterol; 2000 Nov; 14 Suppl D():112D-121D. PubMed ID: 11110623
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [How I treat ... ascites].
    Gielen S; Delwaide J; Detry O; Belaiche J;
    Rev Med Liege; 2001 Dec; 56(12):809-15. PubMed ID: 11820032
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Current treatment of ascites and spontaneous bacterial peritonitis in Spain: analysis of a survey of gastroenterologists and hepatologists].
    Sort P; Ginés P; Navasa M; Arroyo V
    Gastroenterol Hepatol; 1997 Nov; 20(9):437-41. PubMed ID: 9445735
    [TBL] [Abstract][Full Text] [Related]  

  • 52. TIPS for the treatment of refractory ascites, hepatorenal syndrome and hepatic hydrothorax: a critical update.
    Rössle M; Gerbes AL
    Gut; 2010 Jul; 59(7):988-1000. PubMed ID: 20581246
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Ascites].
    Jeong SW
    Korean J Gastroenterol; 2018 Aug; 72(2):49-55. PubMed ID: 30145856
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ascites in Children.
    Bavdekar A; Thakur N
    Indian J Pediatr; 2016 Nov; 83(11):1334-1340. PubMed ID: 27278239
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Automated low-flow ascites pump for the treatment of cirrhotic patients with refractory ascites.
    Stirnimann G; Banz V; Storni F; De Gottardi A
    Therap Adv Gastroenterol; 2017 Feb; 10(2):283-292. PubMed ID: 28203285
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Review article: Management of ascites and associated complications in patients with cirrhosis.
    Kuiper JJ; de Man RA; van Buuren HR
    Aliment Pharmacol Ther; 2007 Dec; 26 Suppl 2():183-93. PubMed ID: 18081661
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Transjugular intrahepatic portosystemic shunts: comparison with paracentesis in patients with cirrhosis and refractory ascites: a randomized trial. French Group of Clinicians and a Group of Biologists.
    Lebrec D; Giuily N; Hadengue A; Vilgrain V; Moreau R; Poynard T; Gadano A; Lassen C; Benhamou JP; Erlinger S
    J Hepatol; 1996 Aug; 25(2):135-44. PubMed ID: 8878773
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Management of ascites in cirrhosis.
    Sandhu BS; Sanyal AJ
    Clin Liver Dis; 2005 Nov; 9(4):715-32, viii. PubMed ID: 16207572
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [New therapeutic paradigm and concepts for patients with cirrhotic refractory ascites].
    Wang SZ; Ding HG
    Zhonghua Gan Zang Bing Za Zhi; 2017 Apr; 25(4):249-253. PubMed ID: 28494541
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Transjugular intrahepatic portosystemic shunts for refractory ascites: assessment of clinical and hormonal response and renal function.
    Somberg KA; Lake JR; Tomlanovich SJ; LaBerge JM; Feldstein V; Bass NM
    Hepatology; 1995 Mar; 21(3):709-16. PubMed ID: 7875668
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.